The number of CD68+ macrophages and the expression of fgl2 were both increased in patients with NAFL and NASH compared with controls, and patients with NASH exhibited higher expression of fgl2 than patients with NAFL (Figure 1C, Figure S2A). This evidence concerns the gene CD68 and metabolic dysfunction-associated steatohepatitis.